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Summary 
Background: About 86% of the cases of cervical cancer occur in developing countries. In Kenya, cervical 
cancer represents 21% of all cancers in women. With a development period as long as ten years, cervical 
cancer is possible to control through screening and treatment. Several projects in reproductive health have 
been offering cervical cancer screening using visual methods through visual inspection with acetic acid or 
visual inspection with Lugol’s iodine (VIA/VILI). Family planning counselling programs are a good opportunity 
to discuss the benefits of cervical cancer screening with gynaecological examination more easily accepted. The 
study looked at the outcomes in relation to screening. 
Methods: A total of 384 women aged 18 – 49 years were enrolled through systematic sampling in the 
descriptive cross sectional study. These were clients who attended the family planning clinic in June-July 
2014. Participants answered questions from semi-structured questionnaires.  
Results: Participants who reported to have been screened for cervical cancer were 15.4%. Those screened 
during the study period were 2.3% and of these, 44.4% had positive VIA/VILI results. Age-group, residence, 
employment status and usual treatment centre were significant in relation to cervical cancer screening uptake.    
Conclusion: The availability of screening services in clinics that clients normally attend does not translate into 
high proportions in cervical cancer screening uptake. However, targeted screening will result in more positive 
cases being reported.  
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Introduction: 
Cancer has become a major source of morbidity and 
mortality globally. Worldwide, breast and cervical cancers 
represent 33% of the new cancer cases in females. 
Cervical cancer is the second most common cancer 
among women worldwide and the tenth most common 
cancer in developed regions [1]. About 86% of the cases 
occur in developing countries [1]. This represents 13% of 
female cancers. High-risk regions include Eastern and 
Western Africa with a cumulative risk (0-74) of 3.8%. 
Age-specific incidence rates peak at around 55-64 years 
[1, 2]. 
Breast cancer represents 22% of all the cancers while 
cervical cancer represents 21% in Kenya as reported at 
the Nairobi Cancer Registry (2003-2007). In Kenya, 
10.32 million women 15 years older are at risk of 
developing cervical cancer [2]. 
Human papillomavirus (HPV) infection is a well-
established cause of cervical cancer and though it is a 
necessary cause, it is not sufficient. Infection with one or 
more of the high-risk oncogenic types leads to invasive 
cervical cancer after around 10 years. About 38.8% of 
women in the general population are estimated to 
harbour cervical HPV infection at a given time. Other 
cofactors associated with the progression from cervical 
HPV infection to cancer include tobacco smoking, high 
parity and age at first sexual intercourse and co-infection 
with HIV [2]. 
Cervical cancer screening can reduce the incidence of 
cancer by early detection and treatment. In an effort to 
reduce the incidence, morbidity and mortality associated 
with cervical cancer, the Kenyan government is placing 
greater emphasis on the need for system strengthening 
to facilitate provision of primary prevention, screening, 
early detection, diagnosis and appropriate management 
of pre cancer and cancers [3].  
Visual inspection with Acetic Acid (VIA) and Visual 
Inspection with Lugol’s Iodine (VILI) are used in low-
resource settings. In Kenya, several projects in 
reproductive health and HIV have been offering cervical 
cancer screening using visual inspection methods 
VIA/VILI [3]. The family planning clinic also offers family 
planning and contraceptive methods services. Despite 
this service being offered, not all clients take up cervical 
cancer screening. 
There are six levels of health care delivery in Kenya 
(Kenya Essential Package for Health-KEPH). 
Specialization increases with each increasing level with 
level 6 being the highest. District and sub-district 
hospitals are in Level 4. They are the first referral 
hospitals and form an integral part of the district health 
system [4]. The family planning clinic is a setting that 
offers the opportunity for health providers to add value to 
the visit of a woman through cervical cancer screening 
[5]. Though easily preventable, the cervical cancer 
screening coverage is low with some studies showing 
that cervical cancer screening uptake lower than 30% [3, 
6, 7]. 
Since most cervical cancer cases are diagnosed late, the 
scope for successful treatment is limited and very 
expensive and consequently the mortality rate is high 
among the affected patients. Cervical cancer thus claims 
the lives of women in the prime of their life. It has been 
estimated that the average life years lost due to cancer of 
the cervix is 25.3 years [3]. Hence the target of the 
national cervical cancer prevention program strategic plan 
is to ensure that women have access to cervical cancer 
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prevention and control services through family planning 
clinics. The objective of the study was to determine the 
uptake of these services through a descriptive study. By 
knowing how these services are working, measures can 
be put in place to make them more effective. This will 
lead to a reduction of incidence of cervical cancer and 
have a positive impact on health and development. 
 
Materials and Methods: 
This was a descriptive cross-sectional study to determine 
cervical cancer screening uptake in a family planning 
clinic.  
Study site 
The study was carried out at Naivasha District Hospital, a 
level four referral hospital located in a major catchment 
area bordering highly populated areas. It is in Naivasha 
District in Nakuru County which lies northwest of Nairobi. 
Naivasha district’s main industry is agriculture especially 
horticulture. It is also a popular tourist destination. It is 
cosmopolitan with many people migrating there in search 
of work. The poverty rate is at 40% and the urban 
population at 45.8% [8, 9]. 
Study participants 
The study population was the clients treated at the family 
planning clinic at the hospital. The sample size was 384 
participants (Cochran formula 1977). With the facility 
attending to approximately 1200 clients during the study 
period, systematic sampling with a sampling interval of 3 
was used to choose the study participants. Those 
included were between 18-49 years of age who were 
willing to give consent and participate. 
Data collection 
Data was obtained through semi-structured 
questionnaires from the study participants. 
Questionnaires were interviewer-administered to 
participants after they were attended to by the healthcare 
providers. Information sought for in the questionnaires 
included socioeconomic factors, access to healthcare, 
exposure to risk factors. 
Data analysis 
Data was entered, cleaned and analysed using Statistical 
Package for Social Sciences (SPSS) version 20.0. The 
economic group level was achieved by first undertaking 
factor analysis. Then the two factors contributing the 
most were analysed using a standardized index (SI) and 
divided into three economic groups [10]. For continuous 
data, distribution characteristics were confirmed using 
Kolmogorov-Sminorv test and Exploratory Data Analysis 
(EDA). The risk level was a composite variable obtained 
by grouping those exposed to any co-factors (like 
tobacco smoking, high parity, and co-infection with HIV 
[2]) necessary for progression of HPV infection to cervical 
cancer and those not exposed. During analysis, the 
participants were divided into three age-groups. This was 
based on high risk HPV being more common in women 
under 25 years and considering the approximately 10 
year-developmental period to cervical cancer, the best 
age to be screened if only screened once is over 35 
years of age [2].    
 
Ethical considerations 
Approval was obtained from the KEMRI Ethical and 
Research Committee and the Scientific Steering 
Committee. All participants provided written informed 
consent. 
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Results: 
Demographic and economic characteristics 
A total of 384 participants were enrolled for the 
descriptive study. Age-group of 25-34 had the highest 
number of participants at 47.4% (Table 1). The 
participants had a mean age of 26.81 with a standard 
deviation of 6.14 and ranged from 18 to 48 years. They 
had a median of 2 children with a minimum of 1 and a 
maximum of 9. A large percentage of the participants, 
94.8% were married. Secondary education had 44.5% of 
the participants followed closely by 42.4% with a primary 
level education. Almost half of the participants, 44.3%, 
were dependent on relatives with 43.2% of them being 
housewives depending on their husbands/partners. 
Those working for an income were either in salaried or 
self-employment and accounted for 55.5%. Those who 
lived in the area near the hospital accounted for 68.5% 
(Table 1). Over three-quarters (83.9%) were living in 
rented houses. 
 
Table1: Socio-demographic characteristics of study participants (N = 384) 
 
Variable Frequency Percent (%) 
Age group (years): 
24 and below 
25-34 
35 and above 
 
160 
182 
42 
 
41.7 
47.4 
10.9 
Marital status: 
Single 
Married (monogamous) 
Married (polygamous) 
Divorced/separated 
Widowed 
 
17 
356 
8 
3 
0 
 
4.4 
92.7 
2.1 
0.8 
0 
Education level: 
None 
Primary 
Secondary 
College (post-secondary) 
 
4 
163 
171 
46 
 
1 
42.4 
44.5 
12 
Source of income: 
Employed (salaried) 
Husband/ partner/relative 
Self-employed 
Non-response 
 
82 
170 
131 
1 
 
21.4 
44.3 
34.1 
0.3 
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Variable Frequency Percent (%) 
Residence: 
Area near the hospital  
Other areas in Naivasha 
Area outside Naivasha 
 
263 
118 
3 
 
68.5 
30.7 
0.8 
Economic level: 
Lower 
Medium 
Higher 
 
30 
347 
7 
 
7.8 
90.4 
1.8 
 
Access to the hospital 
The hospital was the nearest health facility for 83.3% of 
the participants and yet it was the usual health facility 
for 86.7%. Walking to the hospital was the common 
mode of transport for 58.9% of the participants (Table 
2a).
 
Table 2a: Access to hospital 
Variable Frequency 
N=384 
Percent (%) 
Nearest facility to client’s home: 
Yes 
No 
 
320 
64 
 
83.3 
16.7 
Usual facility for health care: 
Yes 
No 
 
333 
51 
 
86.7 
13.3 
Mode of transport: 
Motor vehicle/Matatu 
Walking 
Motorbike 
Both walking and Matatu 
 
120 
226 
36 
2 
 
31.3 
58.9 
9.4 
0.5 
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Table 2b: Access to hospital (continuous variables) 
Variable  N Median Interquartile 
range (IQR) 
Minimum-
Maximum 
Time (minutes) to reach 
hospital via: 
Matatu/Motor vehicle: 
Walking: 
Motorbike: 
Both walking and Matatu: 
 
 
120 
226 
36 
2 
 
 
30 
30 
20 
40 
 
 
20-35 
15-30 
10-30 
40-40 
 
 
5-180 
2-120 
1-60 
40-40 
 
Participants History 
About 20.1% of the study participants reported to being 
exposed to co-factors that increased their risk of 
cervical cancer. For the 99.2% who were using a family 
planning method, 50.9% were on the injectable 
contraceptive method (Table 3).  
 
Table 3: Participants history 
Variable Frequency 
N=384 
Percent (%) 
Client’s risk level on exposure to co-factors: 
Low level 
High level 
 
307 
77 
 
79.9 
20.1 
Method of family planning (N=381) 
Pill 
IUD 
Injectable 
Implant 
Male/female condom 
Non-response 
 
97 
45 
194 
42 
1 
2 
 
25.5 
11.8 
50.9 
11 
0.3 
0.5 
 
Cervical cancer screening uptake 
A total of 59 participants (15.4%, 95% confidential 
interval (CI) 11.8-19.0%) had been screened both from 
ever screened and screened during the study period for 
cervical cancer. Cervical cancer screening uptake as 
reported by participants screened before was higher in 
recent years (Figure 1).  
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Figure 1: Percentage per year for participants reporting having being screened before study period (N=53) 
Variables with a significant p-value of < 0.05 in the bivariate analysis were age group, residence, employment status, 
usual treatment centre (Table 4a,b).  
Table 4a: Association between screening and other variables 
Variable Screened  
P-value Yes = 59 No = 325 
Frequency % Frequency % 
Age group (years): 
24 and below 
25-34 
35 and above 
 
14 
29 
16 
 
23.7 
49.2 
27.1 
 
146 
153 
26 
 
44.9 
47.1 
8.0 
 
 
<0.001 
 
Residence 
Area near Hospital  
Other areas 
 
32 
27 
 
54.2 
45.8 
 
231 
94 
 
71.1 
28.9 
 
 
0.010 
Educational level 
Primary and below 
Secondary and above 
 
25 
34 
 
42.4 
57.6 
 
142 
183 
 
43.7 
56.3 
 
0.851 
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Table 4b: Association between screening and other variables 
Marital status 
Single 
Married (monogamous) 
Married (polygamous) 
Divorced/separated 
 
2 
54 
2 
1 
 
3.4 
91.5 
3.4 
1.7 
 
15 
302 
6 
2 
 
4.6 
92.9 
1.8 
0.6 
 
 
0.436 
Employment status 
Working 
Unemployed 
 
45 
14 
 
76.3 
23.7 
 
168 
156 
 
51.9 
48.1 
 
 
0.001 
Economic level 
Low 
Middle 
High 
 
6 
53 
0 
 
10.2 
89.8 
0 
 
24 
294 
7 
 
7.4 
90.5 
2.2 
 
 
0.544 
 
Nearest facility 
Yes 
No 
 
45 
14 
 
76.3 
23.7 
 
275 
50 
 
84.6 
15.4 
 
 
0.114 
Usual treatment centre: 
Yes 
No 
 
43 
16 
 
72.9 
27.1 
 
290 
35 
 
89.2 
10.8 
 
 
0.001 
Risk of cervical cancer 
High 
Low 
 
17 
42 
 
28.8 
71.2 
 
60 
265 
 
18.5 
81.5 
 
 
0.068 
 
Age group was significant at p=<0.001 with age group 
of 25-34 with the highest frequency at 49.2% of those 
screened. The residence of the participants was also 
significant at p-value of 0.010. Having been screened 
had a higher frequency for those living near the hospital 
at 54.2% compared to those living farther from the 
hospital at 45.8%. Those working were significant at  
 
 
 
p=0.001 with those working having a higher frequency 
(76.3%) of having been screened (Table 4).  
VIA/VILI results among those screened 
During the study period, the prevalence of screening 
was 2.3%. Of these, 44.4% had positive VIA/VILI 
results (Table 5). All of the study participants screened 
(100%) reported that they would tell people they knew 
closely about cervical cancer screening. 
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Table 5: Screening during study period 
Variable Frequency 
N=9 
Percent (%) 
Screened during study period: 
Yes 
No 
 
9  
375  
 
2.3 
97.7 
Screening results: 
Positive VIA/VILI 
Negative VIA/VILI 
 
4  
5  
 
44.4 
55.6 
Tell others know closely of screening(if screened today): 
Yes 
No 
 
9  
0  
 
100 
0 
 
 
Discussion: 
This cross-sectional study determined cervical cancer 
screening uptake in a family clinic which is a setting 
where gynaecological examination is expected to be 
more easily accepted. The overall cervical cancer 
screening uptake was 15.4%. The findings of this study 
show a lower cervical cancer screening uptake 
compared to other regions where a study done in Embu 
County had an uptake of 25% [11] and another in 
Kisumu had 17.5% [12]. However, this study showed 
that in those who had been screened, the percentage 
uptake was higher in the recent years shown in Figure 
1 in contrast to an Eldoret study [13] that showed 
previous screening was uncommon. This could be due 
to increased dissemination of cervical cancer 
information. 
Those screened during the study period were 2.3%. 
This low screening uptake is reflected in other studies 
with 4.1% in low income countries [14], 0.6% in South-
east Nigeria [6] and 22.6% in Moshi Rural District 
Tanzania [7]. A 2010 study in a similar setting in 
Eldoret, Kenya showed an uptake of 12.3% [5]. This 
data shows that though screening has been there for at 
least five years, screening uptake is still low. In 
contrast, high income countries have higher uptake. In 
2009, a study in Italy found that only 65% of women 
regularly undergo pap testing due to public health 
programmes used to promote cancer screening [15]. 
The difference may be due to different knowledge levels 
of cervical cancer between the high- and low-income 
countries. Despite a large number of participants 
reporting that the hospital was the nearest facility the 
target population of 75% to be screened has not been 
reached even with active promotion of cervical cancer 
screening through VIA/VILI [16].  
There was a similar significant association in age 
reported in other studies [12-13, 15]. Similar to the 
Napoli et al., 2011 [15] and a Kisumu [12] studies, a 
significant association was found between having a 
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source of income and cervical cancer screening uptake. 
Screening involves payment and those in the low 
income level may not be able to spare any money. High 
risk participants have been found to be more likely to 
accept screening. A retrospective cohort study done 
using patient chart data from HIV-infected women 
enrolled at a centre in Nairobi found acceptance of 
cervical cancer screening at 44% [17]. Another study 
done on 3642 women in HIV care and treatment clinics 
in Kenya and had an uptake of 87% [18]. Though the 
participants’ level of education was not significant, a 
study in Tanzania [7] found women’s level of education 
was significant in relation to uptake of cervical cancer 
screening service. 
Of those who were screened during the study period 
44.4% had positive VIA/VILI results. A cross sectional 
survey of 219 women in Eldoret found the test positivity 
rate was 13.9% and 16.9% for VIA/VILI respectively 
[5]. Another study was done on 3642 women in HIV 
care and treatment clinics in Kenya found that among 
the women offered screening 15% of them had a 
positive or unsatisfactory VIA [18]. Claeys [19] study 
found 4.5% of Pap smears were abnormal while 
Gatune [20] study reported 4.3%. The reason for the 
high positive results in this study could be as a result 
that participants reporting genital tract problems may be 
targeted for screening. The family planning clinic has 
one nurse at a time resulting in long queues. Clients 
attended to during the study period were 1200. 
According to the World Health Organization, the 
recommended provider: client ratio is 2.3:1000 [4]. The 
result is a limited ability to offer the screening to 
everyone.  
A limitation of this study was that the study participants 
were those accessing family planning services. This 
could mean that the outcome from this study may not 
be generalized to those not using family planning 
services. The family planning clinic also focuses on 
screening using VIA/VILI which is not suitable for 
postmenopausal women [21]. 
 
Conclusion: 
Though there is active promotion of cervical cancer 
screening through VIA/VILI in family planning clinics, it 
does not translate into high proportions in cervical 
cancer screening uptake. This is despite the fact that 
these services are offered in a clinic where clients 
normally attend and gynecological examinations are 
expected to be more easily accepted. When screening 
is targeted on specific cases presenting with symptoms 
or those in the peak age for occurrence of cervical 
cancer (35-45 years), it will result in more positive 
cases being reported than in those studies where 
screening is not based on these factors. These findings 
suggest that more needs to be done by hospital 
management teams and healthcare providers to reach 
those accessing the family planning clinics. This can be 
by easing access to services through the increase of 
the number of VIA/VILI trained healthcare providers and 
screening rooms and improving public health 
programmes used to promote cancer screening 
resulting in an increase in the use of cervical cancer 
screening services. 
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